v3.25.4
Condensed Consolidated Statements of Changes in Stockholders’ Deficit - USD ($)
Preferred Stock
Series A
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total
Balance at Sep. 30, 2022   $ 1,007 $ 25,172,170 $ (14,340,816) $ 58,219 $ 10,890,580
Balance (in Shares) at Sep. 30, 2022   10,074,657        
Retroactive application of reverse stock split   $ (881) 881      
Retroactive application of reverse stock split (in Shares)   (8,815,324)        
Adjusted balance, beginning of period   $ 126 25,173,051 (14,340,816) 58,219 10,890,580
Adjusted balance, beginning of period (in Shares)   1,259,333        
Stock-based compensation     370,878     370,878
Net income (loss)       (17,428,428)   (17,428,428)
Foreign currency translation adjustment         (26,260) (26,260)
Balance at Sep. 30, 2023   $ 126 25,543,929 (31,769,244) 31,959 (6,193,230) [1]
Balance (in Shares) at Sep. 30, 2023   1,259,333        
Net income (loss)           (8,928,095)
Balance at Dec. 31, 2023 $ 174 30,781,934 (40,697,339) (31,354) (9,946,585)
Balance (in Shares) at Dec. 31, 2023 1,737,464        
Balance at Sep. 30, 2023   $ 126 25,543,929 (31,769,244) 31,959 (6,193,230) [1]
Balance (in Shares) at Sep. 30, 2023   1,259,333        
Issuance of stock purchase warrants     517,702     517,702
Issuance of common stock to settle loans payable – related parties   $ 1 270,562     270,563
Issuance of common stock to settle loans payable – related parties (in Shares)   8,767        
Issuance of common stock to settle due to affiliates   $ 9 2,727,051     2,727,060
Issuance of common stock to settle due to affiliates (in Shares)   94,710        
Issuance of common stock in connection with reverse recapitalization   $ 32 150,129     150,161
Issuance of common stock in connection with reverse recapitalization (in Shares)   321,495        
Issuance of common stock to settle accrued expenses and other current liabilities   $ 35 1,880,152     1,880,187
Issuance of common stock to settle accrued expenses and other current liabilities (in Shares)   361,532        
Stock-based compensation     229,605     229,605
Issuance of Old Nukk common stock in exchange for a receivable from Brilliant   $ 5 1,802,210     1,802,215
Issuance of Old Nukk common stock in exchange for a receivable from Brilliant (in Shares)   47,533        
Issuance of Old Nukk common stock to settle accrued expenses and other current liabilities   $ 1 213,385     213,386
Issuance of Old Nukk common stock to settle accrued expenses and other current liabilities (in Shares)   5,629        
Net income (loss)       (8,518,520)   (8,518,520)
Foreign currency translation adjustment         (176,842) (176,842)
Balance at Sep. 30, 2024 $ 209 33,334,725 (40,287,764) (144,883) (7,097,713) [1]
Balance (in Shares) at Sep. 30, 2024 2,098,999        
Balance at Dec. 31, 2023 $ 174 30,781,934 (40,697,339) (31,354) (9,946,585)
Balance (in Shares) at Dec. 31, 2023 1,737,464        
Stock-based compensation 74,668 74,668
Issuance of common stock as compensation for services $ 3 749,997 750,000
Issuance of common stock as compensation for services (in Shares)   25,338        
Net income (loss) (2,429,417) (2,429,417)
Foreign currency translation adjustment 26,582 26,582
Balance at Mar. 31, 2024 $ 177 31,606,599 (43,126,756) (4,772) (11,524,752)
Balance (in Shares) at Mar. 31, 2024 1,762,802        
Balance at Dec. 31, 2023 $ 174 30,781,934 (40,697,339) (31,354) (9,946,585)
Balance (in Shares) at Dec. 31, 2023 1,737,464        
Net income (loss)           409,575
Balance at Sep. 30, 2024 $ 209 33,334,725 (40,287,764) (144,883) (7,097,713) [1]
Balance (in Shares) at Sep. 30, 2024 2,098,999        
Balance at Mar. 31, 2024 $ 177 31,606,599 (43,126,756) (4,772) (11,524,752)
Balance (in Shares) at Mar. 31, 2024 1,762,802        
Allocated value of warrants related to issuance of convertible debt 300,000 300,000
Allocated value of warrants related to debt issuance 40,804 40,804
Issuance of common stock to settle debt $ 9 500,991 501,000
Issuance of common stock to settle debt (in Shares)   87,500        
Stock-based compensation 74,667 74,667
Net income (loss) (1,616,241) (1,616,241)
Foreign currency translation adjustment (5,608) (5,608)
Balance at Jun. 30, 2024 $ 186 32,523,061 (44,742,997) (10,380) (12,230,130)
Balance (in Shares) at Jun. 30, 2024 1,850,302        
Issuance of stock purchase warrants 176,898 176,898
Issuance of common stock to settle accrued expenses and other current liabilities $ 23 629,164 629,187
Issuance of common stock to settle accrued expenses and other current liabilities (in Shares)   248,697        
Stock-based compensation 5,602 5,602
Net income (loss) 4,455,233 4,455,233
Foreign currency translation adjustment (134,503) (134,503)
Balance at Sep. 30, 2024 $ 209 33,334,725 (40,287,764) (144,883) (7,097,713) [1]
Balance (in Shares) at Sep. 30, 2024 2,098,999        
Issuance of common stock to settle accrued expenses and other current liabilities   $ 35 759,958     759,993
Issuance of common stock to settle accrued expenses and other current liabilities (in Shares)   354,660        
Issuance of common stock, net of issuance of costs   $ 25 477,770     477,795
Issuance of common stock, net of issuance of costs (in Shares)   249,263        
Issuance of common stock to settle convertible notes payable   $ 32 771,053     771,085
Issuance of common stock to settle convertible notes payable (in Shares)   319,952        
Issuance of common stock in connection with private placement and embedded derivative, net of issuance costs   $ 23       23
Issuance of common stock in connection with private placement and embedded derivative, net of issuance costs (in Shares)   230,000        
Reclassification of stock purchase warrants from equity-classified to liability-classified     (237,509)     (237,509)
Rounding of post-split shares outstanding per transfer agent   $ 1       1
Rounding of post-split shares outstanding per transfer agent (in Shares)   57        
Stock-based compensation     5,603     5,603
Issuance of common stock as compensation for services   $ 85 1,363,940     1,364,025
Issuance of common stock as compensation for services (in Shares)   847,500        
Issuance of common stock in connection with Exit and Settlement Agreement   $ 14 325,018     325,032
Issuance of common stock in connection with Exit and Settlement Agreement (in Shares)   140,100        
Issuance of common stock as compensation to board of directors   $ 69 959,031     959,100
Issuance of common stock as compensation to board of directors (in Shares)   690,000        
Net income (loss)       (160,787,979)   (160,787,979)
Foreign currency translation adjustment         110,435 110,435
Balance at Dec. 31, 2024 $ 493 37,759,589 (201,075,743) (34,448) (163,350,109) [1]
Balance (in Shares) at Dec. 31, 2024 4,930,531        
Issuance of common stock from exercise of pre-funded warrants $ 8 3,055,806 3,055,814
Issuance of common stock from exercise of pre-funded warrants (in Shares)   83,332        
Stock-based compensation 177,905 177,905
Net income (loss) 102,958,139 102,958,139
Foreign currency translation adjustment (58,765) (58,765)
Balance at Mar. 31, 2025 $ 501 40,993,300 (98,117,604) (93,213) (57,217,016)
Balance (in Shares) at Mar. 31, 2025 5,013,863        
Balance at Dec. 31, 2024 $ 493 37,759,589 (201,075,743) (34,448) (163,350,109) [1]
Balance (in Shares) at Dec. 31, 2024 4,930,531        
Net income (loss)           89,611,236
Balance at Sep. 30, 2025 $ 1,110 81,047,703 (111,464,507) (2,277) (30,417,971)
Balance (in Shares) at Sep. 30, 2025 200 11,096,264        
Balance at Mar. 31, 2025 $ 501 40,993,300 (98,117,604) (93,213) (57,217,016)
Balance (in Shares) at Mar. 31, 2025 5,013,863        
Issuance of common stock in relation to settlement agreement $ 1 157,499 157,500
Issuance of common stock in relation to settlement agreement (in Shares)   12,500        
Issuance of common stock in relation to conversion of note $ 26 780,540 780,566
Issuance of common stock in relation to conversion of note (in Shares)   260,300        
Issuance of common stock from exercise of options $ 9 (9)
Issuance of common stock from exercise of options (in Shares)   84,276        
Net income (loss) 3,018,589 3,018,589
Foreign currency translation adjustment (123,213) (123,213)
Balance at Jun. 30, 2025 $ 537 41,931,330 (95,099,015) (216,426) (53,383,574)
Balance (in Shares) at Jun. 30, 2025 5,370,939        
Issuance of common stock from exercise of warrants $ 502 28,882,963 28,883,465
Issuance of common stock from exercise of warrants (in Shares)   5,023,026        
Issuance of common stock in relation to conversion of note $ 24 1,011,500 1,011,524
Issuance of common stock in relation to conversion of note (in Shares)   243,155        
Issuance of common stock from exercise of options $ 1 1
Issuance of common stock from exercise of options (in Shares)   1,434        
Issuance of common stock for services performed $ 31 1,143,869 1,143,900
Issuance of common stock for services performed (in Shares)   310,000        
Issuance of common stock in exchange for digital assets $ 15 999,860 999,875
Issuance of common stock in exchange for digital assets (in Shares)   147,710        
Issuance of preferred stock in relation to private placement
Issuance of preferred stock in relation to private placement (in Shares) 200          
Issuance of equity-classified warrants 7,080,516 7,080,516
Adjustments in relation to deconsolidation of subsidiary (2,335) 213,716 211,381
Net income (loss) (16,365,492)   (16,365,492)
Foreign currency translation adjustment 433 433
Balance at Sep. 30, 2025 $ 1,110 $ 81,047,703 $ (111,464,507) $ (2,277) $ (30,417,971)
Balance (in Shares) at Sep. 30, 2025 200 11,096,264        
[1] Retroactively restated for the reverse recapitalization as described in Note 1 and Note 4 and the one-for-eight reverse stock split described in Note 10.